BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29167373)

  • 1. Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function.
    Rayon-Estrada V; Harjanto D; Hamilton CE; Berchiche YA; Gantman EC; Sakmar TP; Bulloch K; Gagnidze K; Harroch S; McEwen BS; Papavasiliou FN
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13296-13301. PubMed ID: 29167373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.
    Wolfe AD; Arnold DB; Chen XS
    J Mol Biol; 2019 Mar; 431(7):1506-1517. PubMed ID: 30844405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs.
    Rosenberg BR; Hamilton CE; Mwangi MM; Dewell S; Papavasiliou FN
    Nat Struct Mol Biol; 2011 Feb; 18(2):230-6. PubMed ID: 21258325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
    Blanc V; Xie Y; Kennedy S; Riordan JD; Rubin DC; Madison BB; Mills JC; Nadeau JH; Davidson NO
    RNA; 2019 Jan; 25(1):70-81. PubMed ID: 30309881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.
    Fossat N; Tourle K; Radziewic T; Barratt K; Liebhold D; Studdert JB; Power M; Jones V; Loebel DA; Tam PP
    EMBO Rep; 2014 Aug; 15(8):903-10. PubMed ID: 24916387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
    Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
    RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live-Cell Quantification of APOBEC1-Mediated RNA Editing: A Comparison of RNA Editing Assays.
    Chieca M; Torrini S; Conticello SG
    Methods Mol Biol; 2021; 2181():69-81. PubMed ID: 32729075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-to-U RNA Editing: From Computational Detection to Experimental Validation.
    Lerner T; Kluesner M; Tasakis RN; Moriarity BS; Papavasiliou FN; Pecori R
    Methods Mol Biol; 2021; 2181():51-67. PubMed ID: 32729074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.
    Cole DC; Chung Y; Gagnidze K; Hajdarovic KH; Rayon-Estrada V; Harjanto D; Bigio B; Gal-Toth J; Milner TA; McEwen BS; Papavasiliou FN; Bulloch K
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13272-13277. PubMed ID: 29167375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestine-specific expression of Apobec-1 rescues apolipoprotein B RNA editing and alters chylomicron production in Apobec1 -/- mice.
    Blanc V; Xie Y; Luo J; Kennedy S; Davidson NO
    J Lipid Res; 2012 Dec; 53(12):2643-55. PubMed ID: 22993231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA editing, epitranscriptomics, and processing in cancer progression.
    Witkin KL; Hanlon SE; Strasburger JA; Coffin JM; Jaffrey SR; Howcroft TK; Dedon PC; Steitz JA; Daschner PJ; Read-Connole E
    Cancer Biol Ther; 2015; 16(1):21-7. PubMed ID: 25455629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity.
    Wang S; Kim K; Gelvez N; Chung C; Gout JF; Fixman B; Vermulst M; Chen XS
    J Mol Biol; 2023 Dec; 435(24):. PubMed ID: 38708190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.
    Carouge D; Blanc V; Knoblaugh SE; Hunter RJ; Davidson NO; Nadeau JH
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5425-33. PubMed ID: 27582469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization.
    Teng BB; Ochsner S; Zhang Q; Soman KV; Lau PP; Chan L
    J Lipid Res; 1999 Apr; 40(4):623-35. PubMed ID: 10191286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer.
    Shivalingappa PKM; Sharma V; Shiras A; Bapat SA
    Mol Cell Biochem; 2021 Dec; 476(12):4493-4505. PubMed ID: 34499322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow-cytometric visualization of C>U mRNA editing reveals the dynamics of the process in live cells.
    Severi F; Conticello SG
    RNA Biol; 2015; 12(4):389-97. PubMed ID: 25806564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.
    Chester A; Somasekaram A; Tzimina M; Jarmuz A; Gisbourne J; O'Keefe R; Scott J; Navaratnam N
    EMBO J; 2003 Aug; 22(15):3971-82. PubMed ID: 12881431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
    Severi F; Chicca A; Conticello SG
    Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA editing of BFP, a point mutant of GFP, using artificial APOBEC1 deaminase to restore the genetic code.
    Bhakta S; Sakari M; Tsukahara T
    Sci Rep; 2020 Oct; 10(1):17304. PubMed ID: 33057101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors.
    Grünewald J; Zhou R; Garcia SP; Iyer S; Lareau CA; Aryee MJ; Joung JK
    Nature; 2019 May; 569(7756):433-437. PubMed ID: 30995674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.